Clinical Outcomes with Implementation of Accelerate Pheno™ Blood Culture Detection System for Gram-Negative Bacteremia

Abstract

: Delayed treatment in bacteremia increases patient morbidity and healthcare costs. Accelerate Pheno™ Blood Culture Detection System (AXDX) is a novel diagnostic technology for the rapid detection of gram-negative bacteremia. Studies have shown accurate and faster time to speciation and sensitivity (TTSS) by AXDX compared to conventional modality. However, however, our study further examined the direct impact of AXDX on clinical outcomes and cost. Our retrospective study consisted of 178 patients at least 18 years old admitted to our academic medical institution with gram-negative